Revenue
2022
2023
2024
2025
Futura Medical plc (FUM)
Price£0.00278Cached quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | £1.7M | £13.9M | £3.1M | £0 |
| Research & development | £1.9M | £1.7M | £2.0M | £4.1M |
| Operating expenses | £6.3M | £8.4M | £8.7M | £6.9M |
| Operating income | −£5.1M | £1.2M | −£7.0M | −£6.9M |
| Operating margin | −297.99% | 8.93% | −224.57% | — |
| EBITDA | −£4.9M | £1.4M | −£6.8M | −£6.8M |
| EBITDA margin | −290.80% | 9.81% | −220.37% | — |
| Net income | −£9.1M | £1.3M | −£6.5M | −£5.8M |
| Net profit margin | −534.62% | 9.28% | −210.03% | — |
| Basic EPSper basic share | -£0.03 | £0.00 | £0.02 | -£0.02 |
| Diluted EPSper diluted share | -£0.03 | £0.00 | £0.02 | -£0.02 |
Community posts
Futura upsizes its retail offer to £200,000; the wider financing remains conditional
Futura Medical announced on 7 September 2026 that its retail offer closed oversubscribed on 4 September and was increased from £150,000 to £200,000 gross. Shares and timetable The retail component comprises 100 million shares at 0.2p. It fo ...